Europe Clinical Trials Market By Phase (Phase I, Phase II, Phase III), By Design (Interventional Trials, Observational Trials, Expanded Access Trials), By Indications (Blood Disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Infections, Mental Disorders, Gastrointestinal) and By Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Europe Clinical Trials Market By Phase (Phase I, Phase II, Phase III), By Design (Interventional Trials, Observational Trials, Expanded Access Trials), By Indications (Blood Disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Infections, Mental Disorders, Gastrointestinal) and By Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1653 | Pages: 137 | December 2016 | Region: Europe


The Europe Clinical Trials market has been estimated at USD 3.98 Billion in 2016 and is projected to reach USD 5.61 Billion by 2021, at a CAGR of 7.10% during the forecast period from 2016 to 2021. Clinical trials are experiments done in clinical research. Such prospective biomedical or behavioral research studies on human participants are designed to answer specific questions about biomedical or behavioral interventions, including new treatments and known interventions that warrant further study and comparison. Clinical trials generate data on safety and efficacy.

The market for Clinical Trials is mainly driven due to support from the respective government bodies regarding the smooth performance of clinical trials, advantages such as availability of skilled practitioners and boosted the alliances between the pharma-biotech companies and the clinical research organizations. But, the market growth can be hampered due to stringent regulations and tight R&D budgets in pharma-biotech industry, which are also forcing companies to move to East.

Europe market for Clinical Trials is segmented based on Phase, design and indication. By Phase, the market is further sub-segmented into Phase I, Phase II, Phase III. By design, the market is further sub-segmented into Interventional trials, Observational trials, Expanded Access trials. By indication, the market is further sub-segmented into Autoimmune, Blood disorders, Cancer, Circulatory, CNS, Congenital, CVS, Dermatology, Ear, Gastrointestinal, Genitourinary, Infections, Mental disorders, Metabolic, Musculoskeletal, Nose, Ophthalmology. Cancer and CNS are the largest market share contributors to the market. Segments like Gastrointestinal, Circulatory, Dermatology and Mental Disorders are moving with high CAGR due to their increasing occurrence.

Geographically, Europe market for Clinical Trials is segmented into U.K., Germany, Spain, France and Italy.  Europe is the second biggest market in terms of market share across the globe. The spread of analytics and awareness of its potential are increasing at a rapid rate in Europe. In the European region, Germany heads the largest number of clinical trials due to minimum R&D costs involved when compared to other markets.

Chiltern, Omnicare, PPD, Parexel, Kendle, Quintles, ICON Plc, and Charles River, are the major players of Europe Clinical Trial market.

1.Introduction                                                  

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                               

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                           

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                      

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                       

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 Epidemology                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)            

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                                              

5. Market Segmentation                                                              

                5.1 Phases                                          

                                5.1.1 Introduction                           

                                5.1.2 Phase I                      

                                5.1.3 Phase II                    

                                5.1.4 Phase III                   

                                5.1.5  Y-o-Y Growth Analysis, By Phases                                

                                5.1.6  Market Attractiveness Analysis, By Phases          

                                5.1.7  Market Share Analysis, By Phases                                

                5.2 Design                                          

                                5.2.1 Introduction                           

                                5.2.2 Interventional trials                             

                                5.2.3 Observational trials                             

                                5.2.4 Expanded Access trials                       

                                5.2.5  Y-o-Y Growth Analysis, By Design                 

                                5.2.6  Market Attractiveness Analysis, By Design                 

                                5.2.7  Market Share Analysis, By Design                

                5.3 Indications                                  

                                5.3.1 Introduction                           

                                5.3.2 Autoimmune                         

                                5.3.3 Blood disorders                     

                                5.3.4 Cancer                      

                                5.3.5 Circulatory                               

                                5.3.6 CNS                            

                                5.3.7 Congenital                               

                                5.3.8 CVS                            

                                5.3.9 Dermatology                          

                                5.3.10 Ear                            

                                5.3.11 Gastrointestinal                  

                                5.3.12 Genitourinary                      

                                5.3.13 Infections                              

                                5.3.14 Mental disorders               

                                5.3.15 Metabolic                              

                                5.3.16 Musculoskeletal                 

                                5.3.17 Nose                       

                                5.3.18 Ophthalmology                   

                                5.3.19  Y-o-Y Growth Analysis, By Indications                      

                                5.3.20  Market Attractiveness Analysis, By Indications       

                                5.3.21  Market Share Analysis, By Indications                      

6. Geographical Analysis                                                              

                6.1 Introduction                                               

                                6.1.1 Regional Trends                    

                                6.1.2 Impact Analysis                     

                                6.1.3 Y-o-Y Growth Analysis                        

                                                6.1.3.1 By Geographical Area     

                                                6.1.3.2 By Phase              

                                                6.1.3.3 By Design             

                                                6.1.3.4 By Indication       

                                6.1.4  Market Attractiveness Analysis                     

                                                6.1.4.1 By Geographical Area     

                                                6.1.4.2 By Phase              

                                                6.1.4.3 By Design             

                                                6.1.4.4 By Indication       

                                6.1.5  Market Share Analysis                      

                                                6.1.5.1 By Geographical Area     

                                                6.1.5.2 By Phase              

                                                6.1.5.3 By Design             

                                                6.1.5.4 By Indication       

                6.2 U.K                                 

                6.3 Spain                                             

                6.4 Germany                                     

                6.5 Italy                                               

                6.6 France                                          

7.Strategic Analysis                                                        

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                       

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services                

                                7.2.5 Competitive Rivalry within the Industry                     

8.Market Leaders' Analysis                                                         

                8.1 Chiltern                                        

                                8.1.1 Overview                 

                                8.1.2 Product Analysis                   

                                8.1.3 Financial analysis                  

                                8.1.4 Recent Developments                       

                                8.1.5 SWOT analysis                       

                                8.1.6 Analyst View                          

                8.2 Omnicare                                    

                8.3 PPD                                

                8.4 Parexel                                         

                8.5 Kendle                                          

                8.6 Quintles                                       

                8.7 ICON Plc                                       

                8.8 Charles River                                              

9.Competitive Landscape                                                            

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                       

                9.3 Agreements, collaborations and Joint Ventures                 

                9.4 New Product Launches                                         

10.Market Outlook and Investment Opportunities                                             

Appendix                                                     

                a) List of Tables                                

                b) List of Figures                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Europe Clinical Trial Market By Phase, From 2016-2021 ( USD Billion )
  2. Europe Phase I Market By Region, From 2016-2021 ( USD Billion )
  3. Europe Phase II Market By Region, From 2016-2021 ( USD Billion )
  4. Europe Phase III Market By Region, From 2016-2021 ( USD Billion )
  5. Europe Clinical Trial Market By Design, From 2016-2021 ( USD Billion )
  6. Europe Interventional trials Market By Region, From 2016-2021 ( USD Billion )
  7. Europe Observational trials Market By Region, From 2016-2021 ( USD Billion )
  8. Europe Expanded Access trials Market By Region, From 2016-2021 ( USD Billion )
  9. Europe Clinical Trial Market By Indications, From 2016-2021 ( USD Billion )
  10. Europe Autoimmune Market By Region, From 2016-2021 ( USD Billion )
  11. Europe Blood disorders Market By Region, From 2016-2021 ( USD Billion )
  12. Europe Cancer Market By Region, From 2016-2021 ( USD Billion )
  13. Europe Circulatory Market By Region, From 2016-2021 ( USD Billion )
  14. Europe CNS Market By Region, From 2016-2021 ( USD Billion )
  15. Europe Congenital Market By Region, From 2016-2021 ( USD Billion )
  16. Europe CVS Market By Region, From 2016-2021 ( USD Billion )
  17. Europe Dermatology Market By Region, From 2016-2021 ( USD Billion )
  18. Europe Ear Market By Region, From 2016-2021 ( USD Billion )
  19. Europe Gastrointestinal Market By Region, From 2016-2021 ( USD Billion )
  20. Europe Genitourinary Market By Region, From 2016-2021 ( USD Billion )
  21. Europe Infections Market By Region, From 2016-2021 ( USD Billion )
  22. Europe Mental disorders Market By Region, From 2016-2021 ( USD Billion )
  23. Europe Metabolic Market By Region, From 2016-2021 ( USD Billion )
  24. Europe Musculoskeletal Market By Region, From 2016-2021 ( USD Billion )
  25. Europe Nose Market By Region, From 2016-2021 ( USD Billion )
  26. Europe Ophthalmology Market By Region, From 2016-2021 ( USD Billion )
  27. U.K. Clinical Trial Market By Phase, From 2016-2021 ( USD Billion )
  28. U.K. Clinical Trial Market By Design, From 2016-2021 ( USD Billion )
  29. U.K. Clinical Trial Market By Indications, From 2016-2021 ( USD Billion )
  30. Germany Clinical Trial Market By Phase, From 2016-2021 ( USD Billion )
  31. Germany Clinical Trial Market By Design, From 2016-2021 ( USD Billion )
  32. Germany Clinical Trial Market By Indications, From 2016-2021 ( USD Billion )
  33. France Clinical Trial Market By Phase, From 2016-2021 ( USD Billion )
  34. France Clinical Trial Market By Design, From 2016-2021 ( USD Billion )
  35. France Clinical Trial Market By Indications, From 2016-2021 ( USD Billion )
  36. Italy Clinical Trial Market By Phase, From 2016-2021 ( USD Billion )
  37. Italy Clinical Trial Market By Design, From 2016-2021 ( USD Billion )
  38. Italy Clinical Trial Market By Indications, From 2016-2021 ( USD Billion )
  39. Spain Clinical Trial Market By Phase, From 2016-2021 ( USD Billion )
  40. Spain Clinical Trial Market By Design, From 2016-2021 ( USD Billion )
  41. Spain Clinical Trial Market By Indications, From 2016-2021 ( USD Billion )
North America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Middle East And Africa High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application...
Latin America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Europe High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glau...
Asia Pacific High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology...
High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glaucoma, H...
North America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Middle East And Africa Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pestici...
Latin America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Europe Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...
Asia Pacific Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screeni...
Global Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.